368 related articles for article (PubMed ID: 29912442)
21. Systemic inflammatory regulators and 7 major psychiatric disorders: A two-sample Mendelian randomization study.
Chen X; Yao T; Cai J; Fu X; Li H; Wu J
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Jun; 116():110534. PubMed ID: 35150783
[TBL] [Abstract][Full Text] [Related]
22. Cross-disorder GWAS meta-analysis of endocannabinoid DNA variations in major depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorder, and schizophrenia.
Kim HK; Gonçalves VF; Husain MI; Müller DJ; Mulsant BH; Zai G; Kloiber S
Psychiatry Res; 2023 Dec; 330():115563. PubMed ID: 37924773
[TBL] [Abstract][Full Text] [Related]
23. [Heritability and genetic comorbidity of attention deficit disorder with hyperactivity].
Puddu G; Rothhammer P; Carrasco X; Aboitiz F; Rothhammer F
Rev Med Chil; 2017 Mar; 145(3):368-372. PubMed ID: 28548194
[TBL] [Abstract][Full Text] [Related]
24. Investigating regions of shared genetic variation in attention deficit/hyperactivity disorder and major depressive disorder: a GWAS meta-analysis.
Powell V; Martin J; Thapar A; Rice F; Anney RJL
Sci Rep; 2021 Apr; 11(1):7353. PubMed ID: 33795730
[TBL] [Abstract][Full Text] [Related]
25. Dissecting the association between psychiatric disorders and neurological proteins: a genetic correlation and two-sample bidirectional Mendelian randomization study.
Huang H; Cheng S; Li C; Cheng B; Liu L; Yang X; Meng P; Yao Y; Pan C; Zhang J; Zhang H; Chen Y; Zhang Z; Wen Y; Jia Y; Zhang F
Acta Neuropsychiatr; 2022 Dec; 34(6):311-317. PubMed ID: 35343424
[TBL] [Abstract][Full Text] [Related]
26. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
Cross-Disorder Group of the Psychiatric Genomics Consortium
Lancet; 2013 Apr; 381(9875):1371-1379. PubMed ID: 23453885
[TBL] [Abstract][Full Text] [Related]
27. Widespread signatures of positive selection in common risk alleles associated to autism spectrum disorder.
Polimanti R; Gelernter J
PLoS Genet; 2017 Feb; 13(2):e1006618. PubMed ID: 28187187
[TBL] [Abstract][Full Text] [Related]
28. Shared polygenic risk for ADHD, executive dysfunction and other psychiatric disorders.
Chang S; Yang L; Wang Y; Faraone SV
Transl Psychiatry; 2020 Jun; 10(1):182. PubMed ID: 32518222
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide analysis in UK Biobank identifies four loci associated with mood instability and genetic correlation with major depressive disorder, anxiety disorder and schizophrenia.
Ward J; Strawbridge RJ; Bailey MES; Graham N; Ferguson A; Lyall DM; Cullen B; Pidgeon LM; Cavanagh J; Mackay DF; Pell JP; O'Donovan M; Escott-Price V; Smith DJ
Transl Psychiatry; 2017 Nov; 7(11):1264. PubMed ID: 29187730
[TBL] [Abstract][Full Text] [Related]
30. Genetic variants in miRNAs differentially expressed during brain development and their relevance to psychiatric disorders susceptibility.
Brum CB; Paixão-Côrtes VR; Carvalho AM; Martins-Silva T; Carpena MX; Ulguim KF; Luquez KYS; Salatino-Oliveira A; Tovo-Rodrigues L
World J Biol Psychiatry; 2021 Jul; 22(6):456-467. PubMed ID: 33040684
[TBL] [Abstract][Full Text] [Related]
31. Characterizing the polygenic overlaps of bipolar disorder subtypes with schizophrenia and major depressive disorder.
Li Z; Li D; Chen X
J Affect Disord; 2022 Jul; 309():242-251. PubMed ID: 35487438
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide analyses reveal novel opioid use disorder loci and genetic overlap with schizophrenia, bipolar disorder, and major depression.
Holen B; Shadrin AA; Icick R; Filiz TT; Hindley G; Rødevand L; O'Connell KS; Hagen E; Frei O; Bahrami S; Cheng W; Parker N; Tesfaye M; Jahołkowski P; Karadag N; Dale AM; Djurovic S; Smeland OB; Andreassen OA
Addict Biol; 2023 Jun; 28(6):e13282. PubMed ID: 37252880
[TBL] [Abstract][Full Text] [Related]
33. DCLK1 variants are associated across schizophrenia and attention deficit/hyperactivity disorder.
Håvik B; Degenhardt FA; Johansson S; Fernandes CP; Hinney A; Scherag A; Lybæk H; Djurovic S; Christoforou A; Ersland KM; Giddaluru S; O'Donovan MC; Owen MJ; Craddock N; Mühleisen TW; Mattheisen M; Schimmelmann BG; Renner T; Warnke A; Herpertz-Dahlmann B; Sinzig J; Albayrak Ö; Rietschel M; Nöthen MM; Bramham CR; Werge T; Hebebrand J; Haavik J; Andreassen OA; Cichon S; Steen VM; Le Hellard S
PLoS One; 2012; 7(4):e35424. PubMed ID: 22539971
[TBL] [Abstract][Full Text] [Related]
34. Bivariate genome-wide association analyses of the broad depression phenotype combined with major depressive disorder, bipolar disorder or schizophrenia reveal eight novel genetic loci for depression.
Amare AT; Vaez A; Hsu YH; Direk N; Kamali Z; Howard DM; McIntosh AM; Tiemeier H; Bültmann U; Snieder H; Hartman CA
Mol Psychiatry; 2020 Jul; 25(7):1420-1429. PubMed ID: 30626913
[TBL] [Abstract][Full Text] [Related]
35. Leveraging genetic overlap between irritability and psychiatric disorders to identify genetic variants of major psychiatric disorders.
Jung K; Yoon J; Ahn Y; Kim S; Shim I; Ko H; Jung SH; Kim J; Kim H; Lee DJ; Cha S; Lee H; Kim B; Cho MY; Cho H; Kim DS; Kim J; Park WY; Park TH; O Connell KS; Andreassen OA; Myung W; Won HH
Exp Mol Med; 2023 Jun; 55(6):1193-1202. PubMed ID: 37258574
[TBL] [Abstract][Full Text] [Related]
36. Shared genetic effect of kidney function on bipolar and major depressive disorders: a large-scale genome-wide cross-trait analysis.
Yu S; Lin Y; Yang Y; Jin X; Liao B; Lu D; Huang J
Hum Genomics; 2024 Jun; 18(1):60. PubMed ID: 38858783
[TBL] [Abstract][Full Text] [Related]
37. Structural brain imaging studies offer clues about the effects of the shared genetic etiology among neuropsychiatric disorders.
Radonjić NV; Hess JL; Rovira P; Andreassen O; Buitelaar JK; Ching CRK; Franke B; Hoogman M; Jahanshad N; McDonald C; Schmaal L; Sisodiya SM; Stein DJ; van den Heuvel OA; van Erp TGM; van Rooij D; Veltman DJ; Thompson P; Faraone SV
Mol Psychiatry; 2021 Jun; 26(6):2101-2110. PubMed ID: 33456050
[TBL] [Abstract][Full Text] [Related]
38. A cross-disorder PRS-pheWAS of 5 major psychiatric disorders in UK Biobank.
Leppert B; Millard LAC; Riglin L; Davey Smith G; Thapar A; Tilling K; Walton E; Stergiakouli E
PLoS Genet; 2020 May; 16(5):e1008185. PubMed ID: 32392212
[TBL] [Abstract][Full Text] [Related]
39. Identification of shared risk loci and pathways for bipolar disorder and schizophrenia.
Forstner AJ; Hecker J; Hofmann A; Maaser A; Reinbold CS; Mühleisen TW; Leber M; Strohmaier J; Degenhardt F; Treutlein J; Mattheisen M; Schumacher J; Streit F; Meier S; Herms S; Hoffmann P; Lacour A; Witt SH; Reif A; Müller-Myhsok B; Lucae S; Maier W; Schwarz M; Vedder H; Kammerer-Ciernioch J; Pfennig A; Bauer M; Hautzinger M; Moebus S; Schenk LM; Fischer SB; Sivalingam S; Czerski PM; Hauser J; Lissowska J; Szeszenia-Dabrowska N; Brennan P; McKay JD; Wright A; Mitchell PB; Fullerton JM; Schofield PR; Montgomery GW; Medland SE; Gordon SD; Martin NG; Krasnov V; Chuchalin A; Babadjanova G; Pantelejeva G; Abramova LI; Tiganov AS; Polonikov A; Khusnutdinova E; Alda M; Cruceanu C; Rouleau GA; Turecki G; Laprise C; Rivas F; Mayoral F; Kogevinas M; Grigoroiu-Serbanescu M; Becker T; Schulze TG; Rietschel M; Cichon S; Fier H; Nöthen MM
PLoS One; 2017; 12(2):e0171595. PubMed ID: 28166306
[TBL] [Abstract][Full Text] [Related]
40. Risk and coaggregation of major psychiatric disorders among first-degree relatives of patients with bipolar disorder: a nationwide population-based study.
Chen MH; Hsu JW; Huang KL; Su TP; Li CT; Lin WC; Tsai SJ; Cheng CM; Chang WH; Pan TL; Chen TJ; Bai YM
Psychol Med; 2019 Oct; 49(14):2397-2404. PubMed ID: 30415649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]